Baxter International (BAX) Accumulated Expenses (2009 - 2026)

Baxter International (BAX) has reported Accumulated Expenses for 17 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses fell 11.52% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (down 11.52% YoY), while the FY2025 annual figure was $2.0 billion, up 5.75% from the prior year.
• Accumulated Expenses fell to $1.7 billion in Q2 2026 per BAX's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $2.5 billion in Q3 2023 and bottomed at $1.7 billion in Q2 2026.
• Historically, Accumulated Expenses has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Expenses advanced 28.51% — and 2024, when it sank 30.15%.
• Baxter International's Accumulated Expenses stood at $2.2 billion in 2022, then fell by 11.75% to $1.9 billion in 2023, then declined by 2.82% to $1.9 billion in 2024, then grew by 5.75% to $2.0 billion in 2025, then retreated by 12.96% to $1.7 billion in 2026.
• Business Quant data shows BAX's Accumulated Expenses at $1.7 billion in Q2 2026, $1.8 billion in Q1 2026, and $2.0 billion in Q4 2025.